A. Sidney Barritt

10.3k total citations · 4 hit papers
125 papers, 5.1k citations indexed

About

A. Sidney Barritt is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, A. Sidney Barritt has authored 125 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Epidemiology, 72 papers in Hepatology and 28 papers in Surgery. Recurrent topics in A. Sidney Barritt's work include Liver Disease Diagnosis and Treatment (80 papers), Liver Disease and Transplantation (46 papers) and Organ Transplantation Techniques and Outcomes (18 papers). A. Sidney Barritt is often cited by papers focused on Liver Disease Diagnosis and Treatment (80 papers), Liver Disease and Transplantation (46 papers) and Organ Transplantation Techniques and Outcomes (18 papers). A. Sidney Barritt collaborates with scholars based in United States, United Kingdom and Germany. A. Sidney Barritt's co-authors include Anne F. Peery, Paul H. Hayashi, Evan S. Dellon, Nicholas J. Shaheen, Seth D. Crockett, Robert S. Sandler, Jennifer L. Lund, Elizabeth T. Jensen, Eric S. Orman and Andrew M. Moon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

A. Sidney Barritt

116 papers receiving 5.0k citations

Hit Papers

Burden and Cost of Gastrointestinal, Liver, and Pancreati... 2015 2026 2018 2022 2018 2015 2016 2021 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
    2018 1.1k citations Jennifer L. Lund, A. Sidney Barritt et al. profile →
  2. Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
    2015 670 citations A. Sidney Barritt, Jennifer L. Lund et al. profile →
  3. NAFLD and liver transplantation: Current burden and expected challenges
    2016 320 citations A. Sidney Barritt, Vlad Ratziu et al. Journal of Hepatology profile →
  4. COVID-19 and liver disease: mechanistic and clinical perspectives
    2021 251 citations Thomas Marjot, Gwilym J. Webb et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers

A. Sidney Barritt
Abdel Aziz Shaheen Canada
Shahin Merat Iran
Ross Dierkhising United States
Elizabeth C. Verna United States
Davor Štimac Croatia
Radha K. Dhiman India
Thomas D. Schiano United States
Peter Jepsen Denmark
Tim Card United Kingdom
Elliot B. Tapper United States
Abdel Aziz Shaheen Canada
A. Sidney Barritt
Citations per year, relative to A. Sidney Barritt A. Sidney Barritt (= 1×) peers Abdel Aziz Shaheen

Countries citing papers authored by A. Sidney Barritt

Since Specialization
Citations

This map shows the geographic impact of A. Sidney Barritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sidney Barritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sidney Barritt more than expected).

Fields of papers citing papers by A. Sidney Barritt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sidney Barritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sidney Barritt. The network helps show where A. Sidney Barritt may publish in the future.

Co-authorship network of co-authors of A. Sidney Barritt

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sidney Barritt. A scholar is included among the top collaborators of A. Sidney Barritt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sidney Barritt. A. Sidney Barritt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barritt, A. Sidney, Elliot B. Tapper, Philip N. Newsome, et al.. (2025). Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. The American Journal of Gastroenterology. 121(3). 710–719.
2.
Moon, Andrew M., Sasha Deutsch‐Link, Louise M. Henderson, et al.. (2025). Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular Carcinoma. The American Journal of Gastroenterology. 121(2). 353–361.
3.
Barritt, A. Sidney, Jamie Conklin, Daniel R. Richardson, et al.. (2024). Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinoma. BMC Gastroenterology. 24(1). 90–90. 3 indexed citations
4.
Henderson, Louise M., Bradford E. Jackson, Christopher D. Baggett, et al.. (2023). Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010–2018. Cancer Epidemiology Biomarkers & Prevention. 32(7). 947–956. 2 indexed citations
5.
Lieber, Sarah R., et al.. (2023). Active coping, resilience, post-traumatic growth, and psychiatric symptoms among early and late liver transplant survivors. Liver Transplantation. 29(3). 290–306. 4 indexed citations
6.
Marjot, Thomas, et al.. (2022). SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes. Gut and Liver. 17(1). 12–23. 7 indexed citations
7.
John, Binu V., A. Sidney Barritt, Andrew M. Moon, et al.. (2022). Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis. Clinical Gastroenterology and Hepatology. 20(10). 2405–2408.e3. 6 indexed citations
8.
9.
Lieber, Sarah R., Hannah P. Kim, Randall Teal, et al.. (2021). What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model. Liver Transplantation. 27(10). 1454–1467. 12 indexed citations
10.
Younossi, Zobair M., Maria Stepanova, Fatema Nader, et al.. (2021). Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis. Clinical Gastroenterology and Hepatology. 20(9). 2050–2058.e12. 77 indexed citations
11.
Lieber, Sarah R., Hannah P. Kim, Randall Teal, et al.. (2021). Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective. Liver Transplantation. 28(3). 422–436. 15 indexed citations
12.
Marjot, Thomas, Gustav Buescher, Marcial Sebode, et al.. (2021). SARS-CoV-2 infection in patients with autoimmune hepatitis. Journal of Hepatology. 74(6). 1335–1343. 76 indexed citations
13.
Marjot, Thomas, Gustav Buescher, Marcial Sebode, et al.. (2021). OTH-1 SARS-CoV-2 Infection in patients with autoimmune hepatitis. A7.2–A8. 1 indexed citations
14.
Marjot, Thomas, Gwilym J. Webb, A. Sidney Barritt, et al.. (2021). COVID-19 and liver disease: mechanistic and clinical perspectives. Nature Reviews Gastroenterology & Hepatology. 18(5). 348–364. 251 indexed citations breakdown →
15.
Lieber, Sarah R., Hannah P. Kim, Donna M. Evon, et al.. (2020). What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App. Liver Transplantation. 27(4). 584–589. 8 indexed citations
16.
Moon, Andrew M., et al.. (2020). In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge. PLoS ONE. 15(2). e0229497–e0229497. 10 indexed citations
17.
Chalasani, Naga, Raj Vuppalanchi, Mary E. Rinella, et al.. (2018). Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease. eScholarship (California Digital Library). 1 indexed citations
18.
Barritt, A. Sidney, Norman Gitlin, Samuel Klein, et al.. (2017). Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Contemporary Clinical Trials. 61. 33–38. 39 indexed citations
19.
20.
Liu, Tsai‐Ling, A. Sidney Barritt, Morris Weinberger, et al.. (2016). Who Treats Patients with Diabetes and Compensated Cirrhosis. PLoS ONE. 11(10). e0165574–e0165574. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdel Aziz Shaheen Breakdown of academic impact, for papers by Shahin Merat Breakdown of academic impact, for papers by Ross Dierkhising Breakdown of academic impact, for papers by Elizabeth C. Verna Breakdown of academic impact, for papers by Davor Štimac Breakdown of academic impact, for papers by Radha K. Dhiman Breakdown of academic impact, for papers by Thomas D. Schiano Breakdown of academic impact, for papers by Peter Jepsen Breakdown of academic impact, for papers by Tim Card Breakdown of academic impact, for papers by Elliot B. Tapper
Rankless by CCL
2026